Concepcion C, Xia Y, Korshunova Y, Bligard G, Taylor A, Paley M
iScience. 2025; 28(3):111928.
PMID: 40060903
PMC: 11889669.
DOI: 10.1016/j.isci.2025.111928.
Muto T, Kawaguchi S, Kusuda S, Misu K, Sakamoto M, Machida S
Ophthalmologica. 2024; 248(1):40-53.
PMID: 39571547
PMC: 11901411.
DOI: 10.1159/000542724.
Tayal A, Daigavane S, Gupta N
Cureus. 2024; 16(4):e58867.
PMID: 38800227
PMC: 11116741.
DOI: 10.7759/cureus.58867.
Abu El-Asrar A, Albloushi A, Abouammoh M, Alzubaidi A, Gikandi P, Al Faran A
Eye (Lond). 2023; 38(7):1269-1275.
PMID: 38129662
PMC: 11076456.
DOI: 10.1038/s41433-023-02879-0.
Kim Y, Togloom A, Oh J
Invest Ophthalmol Vis Sci. 2022; 63(9):27.
PMID: 36006654
PMC: 9428358.
DOI: 10.1167/iovs.63.9.27.
Objective evaluation of choroidal melanin loss in patients with Vogt-Koyanagi-Harada disease using polarization-sensitive optical coherence tomography.
Miura M, Makita S, Yasuno Y, Azuma S, Mino T, Yamaguchi T
Sci Rep. 2022; 12(1):3526.
PMID: 35241784
PMC: 8894486.
DOI: 10.1038/s41598-022-07591-9.
Sympathetic Ophthalmia: Where Do We Currently Stand on Treatment Strategies?.
Paulbuddhe V, Addya S, Gurnani B, Singh D, Tripathy K, Chawla R
Clin Ophthalmol. 2021; 15:4201-4218.
PMID: 34707340
PMC: 8542579.
DOI: 10.2147/OPTH.S289688.
Challenging Mimickers in the Diagnosis of Sarcoidosis: A Case Study.
El Jammal T, Jamilloux Y, Gerfaud-Valentin M, Richard-Colmant G, Weber E, Bert A
Diagnostics (Basel). 2021; 11(7).
PMID: 34359324
PMC: 8304686.
DOI: 10.3390/diagnostics11071240.
Three-Dimensional Distribution Of Fundus Depolarization and Associating Factors Measured Using Polarization-Sensitive Optical Coherence Tomography.
Fujita A, Amari T, Ueda K, Azuma K, Inoue T, Komatsu K
Transl Vis Sci Technol. 2021; 10(2):30.
PMID: 34003915
PMC: 7900852.
DOI: 10.1167/tvst.10.2.30.
Role of optical coherence tomography angiography in Vogt-Koyanagi-Harada disease.
Erba S, Govetto A, Scialdone A, Casalino G
GMS Ophthalmol Cases. 2021; 11:Doc06.
PMID: 33796433
PMC: 7982992.
DOI: 10.3205/oc000179.
Predictive Biomarker for Progression Into the Sunset Glow Fundus of Vogt-Koyanagi-Harada Disease, Using Adaptive Binarization of Fundus Photographs.
Komuku Y, Ishikawa H, Ide A, Matsuoka T, Fukuyama H, Okadome T
Transl Vis Sci Technol. 2020; 9(11):10.
PMID: 33133773
PMC: 7552939.
DOI: 10.1167/tvst.9.11.10.
Exudative Retinal Detachment in Ocular Inflammatory Diseases: Risk and Predictive Factors.
Shah D, Al-Moujahed A, Newcomb C, Kacmaz R, Daniel E, Thorne J
Am J Ophthalmol. 2020; 218:279-287.
PMID: 32621891
PMC: 7529966.
DOI: 10.1016/j.ajo.2020.06.019.
Quantitative Analysis of the Choriocapillaris in Uveitis Using En Face Swept-Source Optical Coherence Tomography Angiography.
Chu Z, Weinstein J, Wang R, Pepple K
Am J Ophthalmol. 2020; 218:17-27.
PMID: 32413411
PMC: 7529782.
DOI: 10.1016/j.ajo.2020.05.006.
Unilateral Presentation of Vogt-Koyanagi-Harada Syndrome.
Hosseini S, Dourandish M, Mazouchi M
J Ophthalmic Vis Res. 2020; 15(1):99-103.
PMID: 32128086
PMC: 7001015.
DOI: 10.18502/jovr.v15i1.5954.
Vogt-Koyanagi-Harada (VKH) syndrome: A new perspective for healthcare professionals.
Patil Y, Garg R, Rajguru J, Sirsalmath M, Bevinakatti V, Kumar M
J Family Med Prim Care. 2020; 9(1):31-35.
PMID: 32110561
PMC: 7014871.
DOI: 10.4103/jfmpc.jfmpc_787_19.
Optical coherence tomography angiography in uveitis.
Tranos P, Karasavvidou E, Gkorou O, Pavesio C
J Ophthalmic Inflamm Infect. 2019; 9(1):21.
PMID: 31873858
PMC: 6928173.
DOI: 10.1186/s12348-019-0190-y.
Commentary: Appraisal of histopathological correlations in Vogt-Koyanagi-Harada uveitis.
Murugan S
Indian J Ophthalmol. 2019; 67(7):1219-1221.
PMID: 31238473
PMC: 6611315.
DOI: 10.4103/ijo.IJO_409_19.
Clinicopathological and immunohistochemistry correlation in a case of Vogt-Koyanagi-Harada disease.
Das D, Boddepalli A, Biswas J
Indian J Ophthalmol. 2019; 67(7):1217-1219.
PMID: 31238472
PMC: 6611308.
DOI: 10.4103/ijo.IJO_1800_18.
Long-term changes of retinal pigment epithelium in the eyes with Vogt-Koyanagi-Harada disease observed by adaptive optics imaging.
Nakamura T, Hayashi A, Oiwake T
Clin Ophthalmol. 2019; 13:927-933.
PMID: 31213764
PMC: 6549749.
DOI: 10.2147/OPTH.S199886.
Comparison of clinical characteristics in patients with Vogt-Koyanagi-Harada disease with and without anti-retinal antibodies.
Hashimoto Y, Saito W, Namba K, Mizuuchi K, Iwata D, Noda K
Graefes Arch Clin Exp Ophthalmol. 2019; 257(8):1751-1758.
PMID: 31065846
DOI: 10.1007/s00417-019-04330-1.